Ads
related to: antibody
Search results
J&J scoops up another atopic dermatitis antibody in $1.25B Numab rights deal
FierceBiotech· 7 days agoNot satisfied with just one new immunology deal this month, Johnson & Johnson is plunking down $1.25...
Novel targeted cancer therapies demonstrate activity and safety in metastatic solid tumors
Medical Xpress· 9 hours agoThe studies were featured in an oral abstract session highlighting the development of new molecularly targeted agents. Preliminary data from a Phase I study evaluating the novel antibody ...
Novel vaccine concept generates immune responses that could produce multiple types of HIV...
Medical Xpress· 5 days agoUsing a combination of cutting-edge immunologic technologies, researchers have successfully...
ASCO24: Akeso’s bispecific vvonescimab faces a rocky road ahead in NSCLC
Pharmaceutical Technology via Yahoo Finance· 2 days agoCompared...
Mythic Therapeutics Presents Initial Dose Escalation Data from Ongoing Phase 1 KisMET-01 Study on...
Benzinga· 11 hours agoPreliminary profile supports development of MYTX-011 in multiple subsets of NSCLC Mythic Therapeutics, a clinical-stage biotechnology company committed to the development of next-generation antibody-drug conjugate
Antibody discovery promises new hope in influenza B battle, paves way for universal vaccine
Medical Xpress· 3 days agoSeasonal flu vaccines cover influenza B and the more common influenza A but do not stimulate the broadest possible range of immune responses against both viruses. In addition, people whose immune ...
Team presents promising results from first clinical trial of next-gen antibody in patients with...
Medical Xpress· 9 hours agoThe ongoing trial has already included 104 patients with various types of tumors who had received between one and seven previous courses of treatment. Preliminary results from this phase 1 trial ...
Keymed reports positive efficacy of stapokibart in Phase III clinical trial
Clinical Trials Arena via Yahoo Finance· 18 hours agoStapokibart (CM310) is a highly efficient, humanised antibody targeting the interleukin-4 receptor...
Novel Vaccine Concept Generates Immune Responses that NIH Says Could Produce Multiple Types of HIV...
Sierra Sun Times· 4 days agoUsing a combination of cutting-edge immunologic technologies, researchers have successfully...
Hansa completes randomisation in Phase III trial of imlifidase
Clinical Trials Arena via Yahoo Finance· 21 hours agoImlifidase has received conditional marketing approval in Europe under the trade name IDEFIRIX for...